These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22894965)

  • 1. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar.
    Schaetti C; Ali SM; Hutubessy R; Khatib AM; Chaignat CL; Weiss MG
    Hum Vaccin Immunother; 2012 Sep; 8(9):1223-9. PubMed ID: 22894965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar.
    Schaetti C; Chaignat CL; Hutubessy R; Khatib AM; Ali SM; Schindler C; Weiss MG
    Hum Vaccin; 2011 Dec; 7(12):1299-308. PubMed ID: 22108036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
    Sundaram N; Schaetti C; Merten S; Schindler C; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2016 Jan; 16():36. PubMed ID: 26762151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.
    Schaetti C; Ali SM; Chaignat CL; Khatib AM; Hutubessy R; Weiss MG
    PLoS One; 2012; 7(7):e41527. PubMed ID: 22844489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.
    Merten S; Schaetti C; Manianga C; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2013 Jan; 13():60. PubMed ID: 23339647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.
    Schaetti C; Hutubessy R; Ali SM; Pach A; Weiss MG; Chaignat CL; Khatib AM
    BMC Public Health; 2009 Apr; 9():99. PubMed ID: 19351401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and cultural features of cholera and shigellosis in peri-urban and rural communities of Zanzibar.
    Schaetti C; Khatib AM; Ali SM; Hutubessy R; Chaignat CL; Weiss MG
    BMC Infect Dis; 2010 Nov; 10():339. PubMed ID: 21110853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya.
    Sundaram N; Schaetti C; Chaignat CL; Hutubessy R; Nyambedha EO; Mbonga LA; Weiss MG
    Epidemiol Infect; 2013 Mar; 141(3):639-50. PubMed ID: 22564277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
    Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
    Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
    Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM; Francois J; Sreenivasan N; Wannemuehler K; Faye PC; Tohme RA; Delly P; Deslouches YG; Etheart MD; Dismer AM; Patel R; Date K
    Vaccine; 2019 Oct; 37(43):6348-6355. PubMed ID: 31521413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global oral cholera vaccine use, 2013-2018.
    Pezzoli L;
    Vaccine; 2020 Feb; 38 Suppl 1(Suppl 1):A132-A140. PubMed ID: 31519444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A; Sarkar K; Haldar P; Ghosh R
    Vaccine; 2020 Feb; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "It depends how one understands it:" a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia.
    Heyerdahl LW; Pugliese-Garcia M; Nkwemu S; Tembo T; Mwamba C; Demolis R; Chilengi R; Gessner BD; Guillermet E; Sharma A
    BMC Infect Dis; 2019 May; 19(1):421. PubMed ID: 31088376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
    Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
    Edosa M; Jeon Y; Gedefaw A; Hailu D; Mesfin Getachew E; Mogeni OD; Jang GH; Mukasa D; Yeshitela B; Getahun T; Lynch J; Bouhenia M; Worku Demlie Y; Hussen M; Wossen M; Teferi M; Park SE
    Clin Infect Dis; 2024 Jul; 79(Supplement_1):S20-S32. PubMed ID: 38996040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.